Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of the American College of Cardiology

• Publication date

  2005-01-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JACC.2004.09.065PMID 15653013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

  2004cited by this paper
• Twenty-Year Survival After Coronary Artery Surgery: An Institutional Perspective From Emory University

  2003cited by this paper
• The way I see it: House officers need formal career development

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Clinical and Angiographic Effects of Chronic Calcium Channel Blocker Therapy Continued Beyond First Postoperative Year in Patients With Radial Artery Grafts: Results of a Prospective Randomized Investigation

  2001cited by this paper
• Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.

  2001cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Long-Term Effects on Clinical Outcomes of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation in the Post Coronary Artery Bypass Graft Trial

  2000cited by this paper
• Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.

  2000cited by this paper
• Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators.

  2000cited by this paper
• ACC/AHA guidelines for coronary artery bypass graft surgery

  1999cited by this paper
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

  1999cited by this paper
• Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients. Results from the National Cooperative Cardiovascular Project.

  1999cited by this paper
• Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina

  1999cited by this paper
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

  1999cited by this paper
• Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group.

  1998cited by this paper
• Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.

  1997cited by this paper
• The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.

  1997cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study.

  1996cited by this paper
• Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators.

  1995cited by this paper
• Metoprolol treatment for two years after coronary bypass grafting: effects on exercise capacity and signs of myocardial ischaemia.

  1995cited by this paper
• The MACB Study Group. Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting

  1995cited by this paper
• Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. The MACB Study Group.

  1995cited by this paper
• Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS).

  1995cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

  1994cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.

  1994cited by this paper
• Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study.

  1994cited by this paper
• Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.

  1994cited by this paper
• Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

  1993cited by this paper
• Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.

  1993cited by this paper
• Immediate Postoperative Aspirin Improves Vein Graft Patency Early and Late After Coronary Artery Bypass Graft Surgery: A Placebo‐Controlled, Randomized Study

  1991cited by this paper
• Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.

  1990cited by this paper
• Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.

  1989cited by this paper
• Twelve-year follow-up of survival in the randomized European Coronary Surgery Study.

  1988cited by this paper
• The Cholesterol Lowering Atherosclerosis Study (CLAS): design, methods, and baseline results.

  1987cited by this paper
• Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.

  1985cited by this paper
• Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.

  1985cited by this paper
• The 5 year effect of bypass surgery on relief of angina and exercise performance.

  1985cited by this paper
• Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.

  1984cited by this paper
• Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina.

  1984cited by this paper
• The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.

  1983cited by this paper
• Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data.

  1983cited by this paper
• The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts.

  1982cited by this paper
• Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.

  1981cited by this paper
• Coronary bypass for stable angina: a prospective randomized study.

  1979cited by this paper
• Effects of bypass surgery on the coronary circulation: incidence and effects of vein graft occlusion.

  1977cited by this paper
• Postoperative Changes in Aortocoronary Saphenous Vein Grafts Revisited: Angiographic Studies at Two Weeks and at One Year in Two Series of Consecutive Patients

  1975cited by this paper
• The Prognosis of Patients with Coronary Artery Disease After Coronary Bypass Operations: Time‐Related Progress of 532 Patients with Disabling Angina Pectoris

  1974cited by this paper

• Prevenção Farmacológica Secundária da Doença Arterial Coronariana em Pacientes Submetidos ao Manejo Clínico, Intervenção Coronária Percutânea ou Cirurgia de Revascularização Miocárdica

  2023cites this paper
• Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy.

  2021cites this paper
• Impact of Renin‐Angiotensin System Blockers on Mortality in Veterans Undergoing Cardiac Surgery

  2021cites this paper
• Characteristics and Long-Term Outcomes of Patients with Prior Coronary Artery Bypass Grafting Undergoing Primary Percutaneous Coronary Intervention for ST-segment Elevation Myocardial Infarction.

  2020cites this paper
• Update on Cardiac Catheterization in Patients With Prior Coronary Artery Bypass Graft Surgery.

  2019cites this paper
• Surgical, Pharmacological, and Patient Factors Affecting Early and or Late Outcomes Following Coronary Artery Bypass Grafting Surgery

  2018cites this paper
• Key Drawbacks of Secondary Ischemic Heart Disease Prevention With Drug Therapy: the Role of Combination Fixed Dose Preparations in Solution of This Problem

  2018cites this paper
• Network meta-analysis of antiplatelet therapy following coronary artery bypass grafting (CABG): none versus one versus two antiplatelet agents.

  2018cites this paper
• Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial

  2018cites this paper
• Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials.

  2018cites this paper
• Ключевые недостатки вторичной профилактики ишемической болезни сердца с помощью лекарственной терапии: роль комбинированных препаратов с постоянными дозами в решении проблемы

  2018cites this paper
• Perioperative management of renin-angiotensin-aldosterone system antagonists

  2018cites this paper
• State of the art: optimal medical therapy - competing with or complementary to revascularisation in patients with coronary artery disease?

  2017cites this paper
• Do practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery & coronary angioplasty?

  2017cites this paper
• Optimal medical therapy is vital for patients with coronary artery disease and acute coronary syndromes regardless of revascularization strategy.

  2017influential citation
• The need for providing pharmaceutical care in geriatrics: A case study of diagnostic errors leading to medication-related problems in a patient treatment plan

  2016cites this paper
• Change in the clinical profile of patients referred for coronary artery bypass grafting from 2004 to 2008. Trends in a single-centre study.

  2015cites this paper
• Stable Ischemic Heart Disease

  2015cites this paper
• Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis: Insights from the Atherosclerosis Lesion Progression Intervention Using Niacin Extended Release in Saphenous Vein Grafts (ALPINE-SVG) Pilot Trial.

  2015cites this paper
• Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization with Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Insights From the SYNTAX Trial at 5-Year Follow-Up

  2015cites this paper
• Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Insights From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial at the 5-Year Fol

  2015cites this paper
• Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention.

  2013cites this paper
• Treatment of hypertension in patients undergoing coronary artery by-pass grafting.

  2012cites this paper
• Results of emergency coronary artery bypass grafting for acute myocardial infarction: importance of intraoperative and postoperative cardiac medical therapy.

  2012cites this paper
• The use of beta-blockers and the importance of heart rate control in the perioperative and surgical intensive care settings

  2011cites this paper
• n-3 polyunsaturated fatty acids after coronary artery bypass grafting.

  2011cites this paper
• LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS?

  2010cites this paper
• Percutaneous Coronary Intervention for the Treatment of Saphenous Vein Grafts

  2010cites this paper
• Role of TGF-β1 and MAP Kinases in the Antiproliferative Effect of Aspirin in Human Vascular Smooth Muscle Cells

  2010cites this paper
• Long-term results (three-year) of emergency coronary artery bypass grafting for patients with unstable angina pectoris.

  2010cites this paper
• Mortality reduction with beta-blockers in ischemic cardiomyopathy patients undergoing coronary artery bypass grafting.

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper
• Advances in vein graft intervention

  2010cites this paper
• Post‐ICU Care and Other Complications

  2009cites this paper
• Evaluation of Patients After Coronary Artery Bypass Grafting

  2009cites this paper
• Secondary prevention of ischaemic cardiac events.

  2009cites this paper
• Prior coronary artery bypass graft surgery patients undergoing diagnostic coronary angiography have multiple uncontrolled coronary artery disease risk factors and high risk for cardiovascular events

  2009cites this paper
• Comparison of two-year outcomes in patients undergoing isolated coronary artery bypass grafting with and without peripheral artery disease.

  2009cites this paper
• The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery

  2009cites this paper
• Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).

  2008cites this paper
• Effects of Angiotensin-Converting Enzyme Inhibition in Low-Risk Patients Early After Coronary Artery Bypass Surgery

  2008cites this paper
• Higher platelet activity is present in patients with restenosis after percutaneous coronary intervention compared with patients with an occlusion of coronary artery bypass graft

  2008cites this paper
• Use of Perioperative Cardiac Medical Therapy Among Patients Undergoing Coronary Artery Bypass Graft Surgery

  2008cites this paper
• The comparison of platelet activity between patients with patent vs. occluded coronary artery bypass grafts.

  2007influential citation
• Nitric oxide-releasing aspirin: will it say NO to atherothrombosis?

  2007cites this paper
• What Is the Incidence and Epidemiologic Impact of Perioperative Cardiovascular Complications ?

  2007cites this paper
• Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery disease.

  2007cites this paper
• Functional effects of nitric oxide-releasing aspirin on vein conduits of diabetic patients undergoing CABG.

  2007cites this paper
• Use of the ABC Care Bundle to Standardize Guideline Implementation in a Cardiac Surgical Population: A Pilot Study

  2007cites this paper
• Quality measurement in adult cardiac surgery: part 1--Conceptual framework and measure selection.

  2007cites this paper
• Perioperative use of cardiac medical therapy among patients undergoing coronary artery bypass graft surgery: a systematic review.

  2007cites this paper
• Myocardial Ischemia and Infarction

  2007cites this paper
• Nitric Oxide-Releasing Aspirin in Atherothrombosis: A Remarkable Improvement of an Old Drug

  2007cites this paper
• Navigating the Crossroads of Coronary Artery Disease and Heart Failure

  2006cites this paper
• The year in cardiovascular surgery.

  2006cites this paper
• The year in cardiovascular surgery.

  2006cites this paper
• Gene therapy and coronary artery bypass grafting: current perspectives.

  2006cites this paper
• Cardiac medical therapy post-coronary bypass grafting.

  2005cites this paper
• Cardiac medical therapy following coronary artery bypass graft surgery.

  2005cites this paper
• The year in cardiovascular surgery.

  2004cites this paper
• Letters

  1981cites this paper